Alexander Talpalatski

Array ( [id] => 3452642 [patent_doc_number] => 05451506 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-19 [patent_title] => 'Oncostatin M and novel compositions having anti-neoplastic activity' [patent_app_type] => 1 [patent_app_number] => 8/078707 [patent_app_country] => US [patent_app_date] => 1993-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 19489 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/451/05451506.pdf [firstpage_image] =>[orig_patent_app_number] => 078707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458766 [patent_doc_number] => 05441896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Solid phase assay for use with a physical developer' [patent_app_type] => 1 [patent_app_number] => 8/073961 [patent_app_country] => US [patent_app_date] => 1993-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6117 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441896.pdf [firstpage_image] =>[orig_patent_app_number] => 073961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3538942 [patent_doc_number] => 05480792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays' [patent_app_type] => 1 [patent_app_number] => 8/071203 [patent_app_country] => US [patent_app_date] => 1993-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5338 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480792.pdf [firstpage_image] =>[orig_patent_app_number] => 071203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659495 [patent_doc_number] => 05591770 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Calanolide and related antiretroviral compounds, compositions, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/065618 [patent_app_country] => US [patent_app_date] => 1993-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 17804 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591770.pdf [firstpage_image] =>[orig_patent_app_number] => 065618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803359 [patent_doc_number] => 05830709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Detection method for homologous portions of a class of substances' [patent_app_type] => 1 [patent_app_number] => 8/035452 [patent_app_country] => US [patent_app_date] => 1993-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 12724 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830709.pdf [firstpage_image] =>[orig_patent_app_number] => 035452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685482 [patent_doc_number] => 05663074 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof' [patent_app_type] => 1 [patent_app_number] => 8/032947 [patent_app_country] => US [patent_app_date] => 1993-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 10196 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663074.pdf [firstpage_image] =>[orig_patent_app_number] => 032947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3410442 [patent_doc_number] => 05411868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-02 [patent_title] => 'Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy' [patent_app_type] => 1 [patent_app_number] => 8/021738 [patent_app_country] => US [patent_app_date] => 1993-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4436 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/411/05411868.pdf [firstpage_image] =>[orig_patent_app_number] => 021738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3049759 [patent_doc_number] => 05283197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => 'Method of monitoring collagen degradation' [patent_app_type] => 1 [patent_app_number] => 8/017333 [patent_app_country] => US [patent_app_date] => 1993-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1957 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283197.pdf [firstpage_image] =>[orig_patent_app_number] => 017333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3501402 [patent_doc_number] => 05514376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Cell culture of hepatitis A virus' [patent_app_type] => 1 [patent_app_number] => 8/016486 [patent_app_country] => US [patent_app_date] => 1993-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2307 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514376.pdf [firstpage_image] =>[orig_patent_app_number] => 016486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685392 [patent_doc_number] => 05643714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Method and assay for HTLV' [patent_app_type] => 1 [patent_app_number] => 8/014153 [patent_app_country] => US [patent_app_date] => 1993-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14658 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643714.pdf [firstpage_image] =>[orig_patent_app_number] => 014153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3060883 [patent_doc_number] => 05310653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis' [patent_app_type] => 1 [patent_app_number] => 8/012972 [patent_app_country] => US [patent_app_date] => 1993-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5958 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310653.pdf [firstpage_image] =>[orig_patent_app_number] => 012972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3013975 [patent_doc_number] => 05340718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-23 [patent_title] => 'Method for assaying a human muscular dystrophy protein' [patent_app_type] => 1 [patent_app_number] => 8/009392 [patent_app_country] => US [patent_app_date] => 1993-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10577 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 309 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/340/05340718.pdf [firstpage_image] =>[orig_patent_app_number] => 009392 [rel_patent_id] =>[rel_patent_doc_number] =>)